Changes in serum lipid measurements following acute ischaemic stroke

被引:37
作者
Butterworth, RJ [1 ]
Marshall, WJ [1 ]
Bath, PMW [1 ]
机构
[1] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT CLIN BIOCHEM, LONDON SE5 9PJ, ENGLAND
关键词
cholesterol; ischaemic stroke; HDL cholesterol; LDL cholesterol;
D O I
10.1159/000108156
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strong observational and interventional evidence exists linking hypercholesterolaemia terolaemia and coronary heart disease, such that lowering total cholesterol significantly reduces cardiovascular morbidity and mortality. Increasingly, data LDL cholesterol suggest that hypercholesterolaemia is also an important factor in cerebrovascular atherosclerosis, and possibly for subsequent ischaemic stroke. Measurement of serum cholesterol fractions following acute myocardial infarction must be performed within the first 48 h or delayed for 3 months because serum cholesterol levels significantly fall during the first week. We have studied the temporal changes in serum cholesterol fractions and triglycerides following ischaemic stroke in 72 patients. Significant falls in total cholesterol (TC) as well as HDL and LDL cholesterol were seen during the first week whilst levels normalised by 3 months; TC mean (SD in parentheses) mmol/l, admission vs. 1 week, 5.54 (1.32) vs. 5.13 (1.07), n = 72, 2p < 0.0001, and admission vs. 3 months, 5.54 (1.32) vs. 5.69 (1.30), n = 72, 2p = 0.21. No changes in serum triglycerides were noted. Similar changes occurred in 13 patients with primary haemorrhagic stroke. We conclude that lipid profiles should be assessed within 48 h of stroke onset or delayed for 3 months to avoid inaccurate measurement. Appropriate measurement of serum lipids is important in patients with ischaemic stroke, as subsequent treatment may reduce further coronary and, possibly, cerebral ischaemic events.
引用
收藏
页码:10 / 13
页数:4
相关论文
共 20 条
[1]   CHOLESTEROL REDUCTION AND THE RISK FOR STROKE IN MEN - A METAANALYSIS OF RANDOMIZED, CONTROLLED TRIALS [J].
ATKINS, D ;
PSATY, BM ;
KOEPSELL, TD ;
LONGSTRETH, WT ;
LARSON, EB .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :136-145
[2]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[3]  
Bath P, 1996, J ROY COLL PHYS LOND, V30, P13
[4]   MANAGEMENT OF HYPERLIPEMIA - GUIDELINES OF THE BRITISH-HYPERLIPEMIA-ASSOCIATION [J].
BETTERIDGE, DJ ;
DODSON, PM ;
DURRINGTON, PN ;
HUGHES, EA ;
LAKER, MF ;
NICHOLLS, DP ;
REES, JAE ;
SEYMOUR, CA ;
THOMPSON, GR ;
WINDER, AF ;
WINOCOUR, PH ;
WRAY, R .
POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (811) :359-369
[5]   MEDICAL PROGRESS - PRIMARY PREVENTION OF STROKE [J].
BRONNER, LL ;
KANTER, DS ;
MANSON, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (21) :1392-1400
[6]  
BUTTERWORTH RJ, 1995, CEREBROVASC DIS, V5, P230
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]   EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS [J].
FURBERG, CD ;
ADAMS, HP ;
APPLEGATE, WB ;
BYINGTON, RP ;
ESPELAND, MA ;
HARTWELL, T ;
HUNNINGHAKE, DB ;
LEFKOWITZ, DS ;
PROBSTFIELD, J ;
RILEY, WA ;
YOUNG, B .
CIRCULATION, 1994, 90 (04) :1679-1687
[9]   AN OVERVIEW OF TRIALS OF CHOLESTEROL-LOWERING AND RISK OF STROKE [J].
HEBERT, PR ;
GAZIANO, JM ;
HENNEKENS, CH .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (01) :50-55
[10]   SERUM-LIPID CHANGES FOLLOWING COMPLETED STROKE SYNDROME [J].
HOLLANDERS, FD ;
BURTON, P ;
SHAFAR, J .
POSTGRADUATE MEDICAL JOURNAL, 1975, 51 (596) :386-389